Evidence map›Paper›PMID 41533792›Full record

ArticleScience advances2026

A transposase-derived gene required for human brain development.

Luz Jubierre Zapater, Sara A Lewis, Rodrigo Lopez Gutierrez, Makiko Yamada, Elias Rodriguez-Fos, Merce Planas-Felix, Daniel Cameron, Phillip Demarest, Anika Nabila, Helen S Mueller and 33 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. ThebioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Toward a Unified Theory of Why Young People Develop Cancer.Cold Spring Harbor perspectives in medicine · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors.

Luz Jubierre ZapaterMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0000-0001-9934-1590
Sara A LewisPediatric Movement Disorders Program, Barrow Neurological Institute, Phoenix Children's Hospital, and Departments of Child Health, Neurology, Genetics, and Cellular & Molecular Medicine, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.ORCID 0000-0003-2560-1681
Rodrigo Lopez GutierrezDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID 0009-0008-5413-3286
Makiko YamadaMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0000-0002-7030-9682
Elias Rodriguez-FosBarcelona Supercomputing Center (BSC), Barcelona 08034, Spain.ORCID 0000-0002-2555-0178
Merce Planas-FelixBarcelona Supercomputing Center (BSC), Barcelona 08034, Spain.ORCID 0000-0002-8267-576X
Daniel CameronMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0009-0001-4102-0935
Phillip DemarestMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0009-0005-0330-8785
Anika NabilaDepartment of Pharmacology, Weill Cornell Medical College, New York, NY 10021, USA.
Helen S MuellerMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0000-0001-5813-873X
Junfei ZhaoProgram for Mathematical Genomics, Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, NY 10032, USA.
Paul BerginDepartment of Pharmacology, Weill Cornell Medical College, New York, NY 10021, USA.
Casie ReedMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Tzippora Chwat-EdelsteinMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0009-0009-4170-8535
Alex PagnozziAustralian e-Health Research Centre, CSIRO, Brisbane, Australia.ORCID 0000-0001-7931-1204
Caroline NavaSorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique- Hôpitaux de Paris (APHP), Département de Génétique, Hôpital de la Pitié Salpêtrière, Paris, France.ORCID 0000-0003-1272-0518
Emilie Bourel-PonchelResearch Group on Multimodal Analysis of Brain Function, University of Picardie Jules Verne, Amiens, France.ORCID 0000-0002-7001-0250
Patricia CornejoPhoenix Children's Hospital, Phoenix, AZ 85016, USA.ORCID 0000-0001-5096-6047
Ali DursunHacettepe University, Faculty of Medicine & Institute of Child Health, Department of Pediatric Metabolism, Ankara, Turkey.
R Köksal ÖzgülHacettepe University, Faculty of Medicine & Institute of Child Health, Department of Pediatric Metabolism, Ankara, Turkey.ORCID 0000-0002-0283-635X
Halil Tuna AkarHacettepe University, Faculty of Medicine & Institute of Child Health, Department of Pediatric Metabolism, Ankara, Turkey.ORCID 0000-0003-1982-8046
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-2866-7777
Huma Arshad CheemaDepartment of Pediatric Medicine, Children's Hospital, University of Child Health Sciences, Lahore, Pakistan.ORCID 0000-0002-0463-687X
Muhammad Nadeem AnjumDepartment of Pediatric Medicine, Children's Hospital, University of Child Health Sciences, Lahore, Pakistan.
Giovanni ZifarelliCENTOGENE GmbH, Rostock, Germany.
Peter BauerCENTOGENE GmbH, Rostock, Germany.ORCID 0000-0001-9414-4555
Miriam EssidDepartment of Child and Adolescent Neurology, LR18SP04, National Institute Mongi Ben Hmida of Neurology, University of Tunis El Manar, Tunis, Tunisia.ORCID 0009-0009-8129-164X
Hanene BenrhoumaDepartment of Child and Adolescent Neurology, LR18SP04, National Institute Mongi Ben Hmida of Neurology, University of Tunis El Manar, Tunis, Tunisia.
Meriem Ben HafsaDepartment of Child and Adolescent Neurology, LR18SP04, National Institute Mongi Ben Hmida of Neurology, University of Tunis El Manar, Tunis, Tunisia.ORCID 0000-0003-0022-7523
Ichraf KraouaDepartment of Child and Adolescent Neurology, LR18SP04, National Institute Mongi Ben Hmida of Neurology, University of Tunis El Manar, Tunis, Tunisia.
Carolina I Galaz-MontoyaPediatric Movement Disorders Program, Barrow Neurological Institute, Phoenix Children's Hospital, and Departments of Child Health, Neurology, Genetics, and Cellular & Molecular Medicine, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.
Alex ProektDepartment of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-9272-5337
Xiaolan ZhaoMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Nicholas D SocciBioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Matthew HayesDepartment of Physics and Computer Science, Xavier University of Louisiana, New Orleans, LA 70125, USA.
Yves BigotPhysiologie de la reproduction et des comportements, UMR INRAe 0085 CNRS8247, Centre INRAE Val de Loire, Nouzilly, France.ORCID 0000-0001-9476-0710
Raul RabadanProgram for Mathematical Genomics, Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-7946-9255
Reza MaroofianDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0001-6763-1542
David TorrentsBarcelona Supercomputing Center (BSC), Barcelona 08034, Spain.ORCID 0000-0002-6086-9037
Claudia L KleinmanDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-5158-7126
Michael C KruerPediatric Movement Disorders Program, Barrow Neurological Institute, Phoenix Children's Hospital, and Departments of Child Health, Neurology, Genetics, and Cellular & Molecular Medicine, University of Arizona College of Medicine, Phoenix, AZ 85004, USA.ORCID 0000-0002-1373-7891
Miklos TothDepartment of Pharmacology, Weill Cornell Medical College, New York, NY 10021, USA.ORCID 0000-0001-8545-6362
Alex KentsisMolecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.ORCID 0000-0002-8063-9191

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Towards a quantitative understanding of tumor evolutionR35CA253126 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Raul Rabadan · 2021 to 2026
$5.6M
Genomic Insights into the Neurobiology of Cerebral PalsyR01NS106298 · NINDS · UNIVERSITY OF ARIZONA · PI KRUER, MICHAEL C · 2019 to 2023
$3.7M
Genomic analysis of the Multiplex, Autozygous Populations in Cerebral Palsy (MAP CP) cohort: a focused approach to a complex diseaseR01NS127108 · NINDS · UNIVERSITY OF ARIZONA · PI Michael C Kruer · 2023 to 2026
$2.6M
Structure and function of genome plasticity in human cancerR01CA214812 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI KENTSIS, ALEX · 2018 to 2022
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA214812NCI NIH HHS R35 CA253126NINDS NIH HHS R01 NS106298NINDS NIH HHS R01 NS127108
6 · The paper itself

Abstract

Vertebrate brain development is associated with prominent neuronal cell death and DNA breaks, but their causes and functions are not well understood. DNA transposable elements could contribute to somatic genome rearrangements; however, their contributions to brain development are largely unknown. PiggyBac transposable element derived 5 (PGBD5) is an evolutionarily conserved vertebrate DNA transposase-derived gene with DNA remodeling activities in human cells. Here, we show that PGBD5 contributes to normal brain development in mice and humans, and its deficiency causes disorder of intellectual disability, movement disorders, and epilepsy. In mice, Pgbd5 is required for the developmental induction of postmitotic DNA breaks and recurrent somatic brain genome rearrangements. In the cerebral cortex, loss of Pgbd5 leads to aberrant neuronal gene expression, including of specific types of glutamatergic neurons, which partly explains the features of PGBD5 deficiency in humans. Thus, PGBD5 is a transposase-derived gene required for brain development in mammals.

Indexed as

BrainTransposasesAnimalsDNA Transposable ElementsGene Expression Regulation, DevelopmentalHumansMiceNeurodevelopmentNeuronsDNA Transposable ElementsTransposases

Identifiers

PMID41533792
PMCPMC12802831

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.